title: Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
authors.affiliation: Biogen Idec Inc., Cambridge, MA, USA.
authors.forename: V
authors.initials: V
authors.lastname: Viglietta
authors.affiliation: Biogen Idec Inc., Cambridge, MA, USA.
authors.forename: J
authors.initials: J
authors.lastname: O'Gorman
authors.affiliation: Biogen Idec Inc., Cambridge, MA, USA.
authors.forename: M
authors.initials: M
authors.lastname: Yang
authors.affiliation: Biogen Idec Inc., Cambridge, MA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Zhang
authors.affiliation: Biogen Idec Inc., Cambridge, MA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Raghupathi